Aurora Cannabis Inc., a Canadian based leading global medical cannabis company, applauds the German government’s final endorsement of cannabis legalization, marking a significant step forward in bolstering patient access to medical cannabis with the official passing of the Cannabis Act.
This change presents long overdue reform in favour of a more accessible medical cannabis market and commitment to patients. This reform follows the progressive change in leading countries like Canada and will serve as a benchmark for global expansion.
“Germany’s reform brings significant advancements in patient access to medical cannabis and a much-needed liberal approach to cannabis that we have advocated in favour of,” emphasized Dirk Heitepriem, Vice President, External Affairs, Aurora Europe, GmbH. “As a market leader, Aurora has been a steadfast supporter of patients. With cannabis de-scheduling, more patients gain access to treatment, reinforcing our dedication to patient outreach and comprehensive access to quality medical cannabis. Today’s improved access underscores our commitment to see progressive change.”
Alongside the cultural significance of Germany’s advancements in cannabis legalization, these developments offer a distinct opening for Aurora, a leading provider of medical cannabis in Germany, to enhance its established footprint in the country.
The reclassification of cannabis as a non-narcotic is poised to inspire more patients to actively consult with their physician regarding medical cannabis, facilitating greater access, education, and awareness for medical cannabis. Aurora once again congratulates the German government on the successful passing of cannabis law reforms that provide for improved patient care.
For further information about medical cannabis products, doctors and health care professionals can contact Aurora Medical.
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult- use brand portfolio includes Drift, San Rafael ’71, Daily Special, Tasty’s, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America’s leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn.
